Literature DB >> 12670633

18F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective.

M Schirmer1, K T Calamia, M Wenger, A Klauser, C Salvarani, R Moncayo.   

Abstract

18F-Fluorodeoxyglucose-positron emission tomography (18F-FDG-PET) is a new functional imaging technique available for clinical and experimental use. 18F-FDG-PET studies can be used for screening, localization and follow-up of hypermetabolic processes including malignancies, infections and autoimmune processes. For several years it has been applied in oncological, cardiological and neurological patients, but nowadays an increasing number of studies favours its use in patients with autoimmune diseases including large vessel arteritis. From the experimental view, this technique has even become more important since the introduction of a small PET scanner for the use in animal models. This review focuses on technical aspects, clinical experiences and experimental and future perspectives of 18F-FDG-PET, with a special emphasis on large vessel vasculitis and other autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670633     DOI: 10.1016/s0531-5565(02)00267-x

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  9 in total

1.  18FDG imaging of giant cell arteritis: usefulness of whole-body plus brain PET.

Authors:  Tarik Belhocine
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-29       Impact factor: 9.236

2.  [Expectations of rheumatologists on imaging results].

Authors:  C Dejaco; C Duftner; M Schirmer
Journal:  Radiologe       Date:  2012-02       Impact factor: 0.635

3.  A plea for the elective inclusion of the brain in routine whole-body FDG PET.

Authors:  Tarik Belhocine; Stefan Markus Weiner; Ingo Brink; Peter Paul De Deyn; Jan Roland; Thierry Van der Borght; Patrick Flamen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

4.  Positron emission tomography/computed tomography improves diagnostics of inflammatory arteritis.

Authors:  Knut Kröger; Gerald Antoch; Mathias Goyen; Lutz S Freudenberg; Patrick Veit; Ilse Janicke; Andreas Bockisch; Michael Forsting
Journal:  Heart Vessels       Date:  2005-07       Impact factor: 2.037

5.  Effect of rolipram on relative 14C-deoxyglucose uptake in inflammatory lesions and skeletal muscle.

Authors:  Miho Shukuri; Masahiro Terai; Rie Hosoi; Tsunehiko Nishimura; Antony Gee; Osamu Inoue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-15       Impact factor: 9.236

6.  18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnosis and Post-Therapeutic Treatment in a Patient with an Early Stage of Retroperitoneal Fibrosis.

Authors:  Artor Niccoli Asabella; A Nicoletti; C Altini; A Notaristefano; G Lastilla; G Rubini
Journal:  Mol Imaging Radionucl Ther       Date:  2013-08-01

7.  The elements of life and medicines.

Authors:  Prinessa Chellan; Peter J Sadler
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2015-03-13       Impact factor: 4.226

8.  Evaluation of mild hypothermia therapy for neonatal hypoxic-ischaemic encephalopathy on brain energy metabolism using 18F-fluorodeoxyglucose positron emission computed tomography.

Authors:  Mei Luo; Qingping Li; Wenbin Dong; Xuesong Zhai; Lan Kang
Journal:  Exp Ther Med       Date:  2014-08-06       Impact factor: 2.447

Review 9.  Indications for diagnostic use of nuclear medicine in rheumatology: A mini-review.

Authors:  Martin Wenger; Michael Schirmer
Journal:  Front Med (Lausanne)       Date:  2022-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.